>
Organization
Neurocrine Biosciences Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Neurocrine Biosciences Inc.

... PR Newswire Neurocrine Biosciences, Inc. (NASDAQ: NBIX) will present at the Jefferies 2018 London Healthcare Conference at ...
... helped guide drug discovery efforts including collaborations with Bayer in oncology. RELATED: Neurocrine, Jnana team up to discover CNS drugs In December 2017, Jnana raised ...
... PR Newswire Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced its financial results for the quarter ended September ...
... PR Newswire Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced it will present new data analyses on the ...
... 35 years of industry experience, including as Chief Executive Officer of Neurocrine Biosciences, Inc., a position he held from 1993 through 2008. Mr. Lyons remains ...
... with careful profit-taking throughout the third quarter. Some shares of Regeneron and Neurocrine were also sold for tactical reasons. Profits were invested in Scholar Rock, ...
... SAN DIEGO - Neurocrine Biosciences, Inc.(NASDAQ: NBIX) announced today that it will report third quarter financial results ...
... PR Newswire Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it will report third quarter financial results ...
... Neurocrine Biosciences has teamed up with Jnana Therapeutics to develop drugs that target ...
Subscribe now for full coverage on Neurocrine Biosciences Inc.
Start My Free Trial